欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O81 Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP482714EOP
CSB-EP482714EOP
CSB-BP482714EOP
CSB-MP482714EOP
CSB-EP482714EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Protein FdhD (fdhD) CSB-YP482715EOP
CSB-EP482715EOP
CSB-BP482715EOP
CSB-MP482715EOP
CSB-EP482715EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Regulator of ribonuclease activity A (rraA) CSB-YP482716EOP
CSB-EP482716EOP
CSB-BP482716EOP
CSB-MP482716EOP
CSB-EP482716EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 50S ribosomal protein L1 (rplA) CSB-YP482717EOP
CSB-EP482717EOP
CSB-BP482717EOP
CSB-MP482717EOP
CSB-EP482717EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP482718EOP
CSB-EP482718EOP
CSB-BP482718EOP
CSB-MP482718EOP
CSB-EP482718EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 4-hydroxybenzoate octaprenyltransferase (ubiA), partial CSB-YP482719EOP1
CSB-EP482719EOP1
CSB-BP482719EOP1
CSB-MP482719EOP1
CSB-EP482719EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Probable apo-citrate lyase phosphoribosyl-dephospho-CoA transferase (citX) CSB-YP482720EOP
CSB-EP482720EOP
CSB-BP482720EOP
CSB-MP482720EOP
CSB-EP482720EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 LPS-assembly lipoprotein lptE (lptE) CSB-YP482721EOP
CSB-EP482721EOP
CSB-BP482721EOP
CSB-MP482721EOP
CSB-EP482721EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Chromosome partition protein MukB (mukB), partial CSB-YP482722EOP
CSB-EP482722EOP
CSB-BP482722EOP
CSB-MP482722EOP
CSB-EP482722EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Methylglyoxal synthase (mgsA) CSB-YP482723EOP
CSB-EP482723EOP
CSB-BP482723EOP
CSB-MP482723EOP
CSB-EP482723EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Fumarate reductase subunit C (frdC), partial CSB-YP482724EOP1
CSB-EP482724EOP1
CSB-BP482724EOP1
CSB-MP482724EOP1
CSB-EP482724EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 L-ribulose-5-phosphate 4-epimerase UlaF (ulaF) CSB-YP482725EOP
CSB-EP482725EOP
CSB-BP482725EOP
CSB-MP482725EOP
CSB-EP482725EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Aspartate carbamoyltransferase regulatory chain (pyrI) CSB-YP482726EOP
CSB-EP482726EOP
CSB-BP482726EOP
CSB-MP482726EOP
CSB-EP482726EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 50S ribosomal protein L9 (rplI) CSB-YP482727EOP
CSB-EP482727EOP
CSB-BP482727EOP
CSB-MP482727EOP
CSB-EP482727EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Phosphopentomutase (deoB) CSB-YP482728EOP
CSB-EP482728EOP
CSB-BP482728EOP
CSB-MP482728EOP
CSB-EP482728EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB (rutB) CSB-YP482729EOP
CSB-EP482729EOP
CSB-BP482729EOP
CSB-MP482729EOP
CSB-EP482729EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Multidrug resistance protein MdtG (mdtG), partial CSB-YP482730EOP
CSB-EP482730EOP
CSB-BP482730EOP
CSB-MP482730EOP
CSB-EP482730EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Beta-hexosaminidase (nagZ) CSB-YP482731EOP
CSB-EP482731EOP
CSB-BP482731EOP
CSB-MP482731EOP
CSB-EP482731EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Probable septum site-determining protein MinC (minC) CSB-YP482732EOP
CSB-EP482732EOP
CSB-BP482732EOP
CSB-MP482732EOP
CSB-EP482732EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP482733EOP
CSB-EP482733EOP
CSB-BP482733EOP
CSB-MP482733EOP
CSB-EP482733EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×